End-of-Year Ask the Experts Round Up

| SCAD Alliance | Latest News
Is SCAD heart disease? Can I ride a roller coaster?
In the past six months, SCAD Alliance has solicited survivors’ questions to be reviewed and answered by an expert panel during our monthly webinars. Today, we close out the year by answering some unique questions and recapping some of the hot topics survivors care about. Use this link to listen to the recording: https://www.youtube.com/watch?v=baXBAy-hwXc&t=645sOur panelists will engage in conversation to help us all understand and feel more comfortable with our SCAD diagnosis. Meet the experts:
Dr. Anna Grodzinsky is a cardiologist at Saint Luke’s Hospital of Kansas City with a special interest is women’s cardiovascular disease and spontaneous coronary artery dissection (SCAD). Dr. Grodzinsky completed her postgraduate training in Internal Medicine and Cardiovascular Disease, and completed a Cardiovascular Outcomes fellowship at Saint Luke’s Hospital. Dr. Grodzinsky is involved and passionate about cardiovascular research, notably now serving as Principal Investigator of the iSCAD Registry site at Saint Luke’s.

 
Dr. Bryan J. Wells is a cardiologist at Emory University, and is board certified in Internal Medicine, Cardiology, Vascular Medicine, Echocardiography, Vascular Interpretation and Nuclear Cardiology. Dr. Wells has a special interest in fibromuscular dysplasia (FMD), SCAD, other arteriopathies, and vascular diseases. Dr. Wells is Principal Investigator of the iSCAD Registry site at Emory University, and part of the Fibromuscular Dysplasia Program, which has a multi-specialty team providing comprehensive, coordinated care including evaluation, diagnosis, genetics, medical treatment, invasive procedures (when needed) and surveillance.

 
Dr. Sahar Naderi is a cardiologist and Director of Women’s Heart Health at Kaiser Permanente, San Francisco. Dr. Naderi has expertise in conditions that disproportionately impact women, specifically SCAD, as well as aortic diseases, including genetic conditions such as Marfan Syndrome, and other rare vascular conditions. SCAD Alliance appreciates all Dr. Naderi contributes to our organization as a scientific adviser, member of the iSCAD Registry Steering Committee and Principal Investigator of the iSCAD Registry site at Kaiser San Francisco.
Back to Latest News